WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006017318) METHODS FOR TREATING CANCER USING AGENTS THAT INHIBIT WNT16 SIGNALING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/017318    International Application No.:    PCT/US2005/024759
Publication Date: 16.02.2006 International Filing Date: 11.07.2005
IPC:
A61K 38/00 (2006.01), A61K 31/70 (2006.01), C07K 16/00 (2006.01), C12N 5/00 (2006.01), C07H 21/02 (2006.01), C07H 21/04 (2006.01), C12Q 1/68 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; Office of Technology Transfer, 1111 Franklin Street, 12th Floor, Oakland, CA 94607 (US) (For All Designated States Except US).
YOU, Liang [US/US]; (US) (For US Only).
HE, Biao [CN/US]; (US) (For US Only).
XU, Zhidong [US/US]; (US) (For US Only).
JABLONS, David, M. [US/US]; (US) (For US Only)
Inventors: YOU, Liang; (US).
HE, Biao; (US).
XU, Zhidong; (US).
JABLONS, David, M.; (US)
Agent: RUPPERT, Siegfried; Townsend and Townsend and Crew LLP, 2 Embarcadero Center, 8th Floor, San Francisco, CA 94111 (US)
Priority Data:
60/586,564 09.07.2004 US
60/645,709 20.01.2005 US
Title (EN) METHODS FOR TREATING CANCER USING AGENTS THAT INHIBIT WNT16 SIGNALING
(FR) METHODES DESTINEES A TRAITER LE CANCER AU MOYEN D'AGENTS INHIBANT LA SIGNALISATION DE WNT16
Abstract: front page image
(EN)This invention relates to methods of inhibiting the growth of cells, in particular cancer cells that over express Wnt16 protein. The methods comprise contacting the cell with an agent that binds to Wnt16 mRNA or Wnt16 protein, interferes with Wnt16 signaling or inhibits binding of the Wnt16 protein to another protein, such as a Frizzled receptor.
(FR)L'invention concerne des méthodes destinées à inhiber la croissance de cellules, et notamment de cellules cancéreuses surexprimant la protéine Wnt16. Ces méthodes consistent à mettre la cellule en contact avec un agent qui se lie à l'ARN messager de Wnt16 ou à la protéine Wnt16, qui interfère avec la signalisation de Wnt16 ou qui inhibe la liaison de la protéine Wnt16 à une autre protéine, telle que le récepteur Frizzled.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)